INOVIQ Balance Sheet Health

Financial Health criteria checks 6/6

INOVIQ has a total shareholder equity of A$20.0M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$21.7M and A$1.7M respectively.

Key information

0%

Debt to equity ratio

AU$0

Debt

Interest coverage ration/a
CashAU$9.23m
EquityAU$19.99m
Total liabilitiesAU$1.72m
Total assetsAU$21.71m

Recent financial health updates

Recent updates

We Think INOVIQ (ASX:IIQ) Can Afford To Drive Business Growth

Apr 22
We Think INOVIQ (ASX:IIQ) Can Afford To Drive Business Growth

A Look At The Intrinsic Value Of INOVIQ Ltd (ASX:IIQ)

Mar 01
A Look At The Intrinsic Value Of INOVIQ Ltd (ASX:IIQ)

We Think Shareholders May Want To Consider A Review Of INOVIQ Ltd's (ASX:IIQ) CEO Compensation Package

Nov 22
We Think Shareholders May Want To Consider A Review Of INOVIQ Ltd's (ASX:IIQ) CEO Compensation Package

Companies Like INOVIQ (ASX:IIQ) Are In A Position To Invest In Growth

Jun 21
Companies Like INOVIQ (ASX:IIQ) Are In A Position To Invest In Growth

Companies Like INOVIQ (ASX:IIQ) Are In A Position To Invest In Growth

Feb 16
Companies Like INOVIQ (ASX:IIQ) Are In A Position To Invest In Growth

INOVIQ (ASX:IIQ) Is In A Good Position To Deliver On Growth Plans

Sep 28
INOVIQ (ASX:IIQ) Is In A Good Position To Deliver On Growth Plans

We're Hopeful That INOVIQ (ASX:IIQ) Will Use Its Cash Wisely

Jun 08
We're Hopeful That INOVIQ (ASX:IIQ) Will Use Its Cash Wisely

We're Keeping An Eye On INOVIQ's (ASX:IIQ) Cash Burn Rate

Jan 28
We're Keeping An Eye On INOVIQ's (ASX:IIQ) Cash Burn Rate

Are Insiders Selling BARD1 Life Sciences Limited (ASX:BD1) Stock?

Mar 02
Are Insiders Selling BARD1 Life Sciences Limited (ASX:BD1) Stock?

Don't Ignore The Fact That This Insider Just Sold Some Shares In BARD1 Life Sciences Limited (ASX:BD1)

Mar 02
Don't Ignore The Fact That This Insider Just Sold Some Shares In BARD1 Life Sciences Limited (ASX:BD1)

BARD1 Life Sciences (ASX:BD1) Is In A Good Position To Deliver On Growth Plans

Dec 28
BARD1 Life Sciences (ASX:BD1) Is In A Good Position To Deliver On Growth Plans

Financial Position Analysis

Short Term Liabilities: IIQ's short term assets (A$10.9M) exceed its short term liabilities (A$1.5M).

Long Term Liabilities: IIQ's short term assets (A$10.9M) exceed its long term liabilities (A$184.6K).


Debt to Equity History and Analysis

Debt Level: IIQ is debt free.

Reducing Debt: IIQ had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: IIQ has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: IIQ has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 20.9% each year.


Discover healthy companies